Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson's disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study.
Rashid-López R, Macías-García P, Sánchez-Fernández FL, Cano-Cano F, Sarrias-Arrabal E, Sanmartino F, Méndez-Bértolo C, Lozano-Soto E, Gutiérrez-Cortés R, González-Moraleda Á, Forero L, López-Sosa F, Zuazo A, Gómez-Molinero R, Gómez-Ramírez J, Paz-Expósito J, Rubio-Esteban G, Espinosa-Rosso R, Cruz-Gómez ÁJ, González-Rosa JJ. Rashid-López R, et al. Among authors: forero l. Front Aging Neurosci. 2023 Oct 5;15:1258315. doi: 10.3389/fnagi.2023.1258315. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37869372 Free PMC article.
Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E, Cruz-López ÁJ, Gutiérrez R, González M, Sanmartino F, Rashid-Lopez R, Espinosa-Rosso R, Forero L, González-Rosa JJ. Lozano-Soto E, et al. Among authors: forero l. Arch Clin Neuropsychol. 2021 May 21;36(4):475-484. doi: 10.1093/arclin/acaa088. Arch Clin Neuropsychol. 2021. PMID: 33067616
Erratum to: Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
Lozano-Soto E, Cruz-Gómez ÁJ, Gutiérrez R, González M, Sanmartino F, Rashid-Lopez R, Espinosa-Rosso R, Forero L, González-Rosa JJ. Lozano-Soto E, et al. Among authors: forero l. Arch Clin Neuropsychol. 2021 Aug 31;36(6):1019. doi: 10.1093/arclin/acab063. Arch Clin Neuropsychol. 2021. PMID: 34259311 Free article. No abstract available.
Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis.
Cruz-Gomez ÁJ, Forero L, Lozano-Soto E, Cano-Cano F, Sanmartino F, Rashid-López R, Paz-Expósito J, Gómez Ramirez JD, Espinosa-Rosso R, González-Rosa JJ. Cruz-Gomez ÁJ, et al. Among authors: forero l. Neurol Neuroimmunol Neuroinflamm. 2021 Aug 31;8(6):e1074. doi: 10.1212/NXI.0000000000001074. Print 2021 Nov. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34465616 Free PMC article.
Deciphering Multiple Sclerosis Progression.
Meca-Lallana V, Berenguer-Ruiz L, Carreres-Polo J, Eichau-Madueño S, Ferrer-Lozano J, Forero L, Higueras Y, Téllez Lara N, Vidal-Jordana A, Pérez-Miralles FC. Meca-Lallana V, et al. Among authors: forero l. Front Neurol. 2021 Apr 7;12:608491. doi: 10.3389/fneur.2021.608491. eCollection 2021. Front Neurol. 2021. PMID: 33897583 Free PMC article. Review.
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Sancho-Saldaña A, Gil-Sánchez A, González-Mingot C, Peralta S, Solana MJ, Torres P, Juanes A, Quibus L, Ruiz E, Sanpedro E, Quirant-Sánchez B, Martínez-Cáceres E, Ramo Tello C, Presas-Rodríguez S, García Rubio S, Baron BP, Ramió-Torrentà L, Sotoca J, González-Suárez I, Eichau S, Prieto-González JM, Blasco Quilez MR, Sabín-Muñoz J, Sánchez-López AJ, Llorens Calatayud G, Calles C, Sempere ÁP, Garcés M, Carmona O, Moral E, Hervás JV, Blanco Y, Sola-Valls N, Tellez Lara N, Forero L, Brieva L. Sancho-Saldaña A, et al. Among authors: forero l. J Clin Med. 2023 Nov 23;12(23):7243. doi: 10.3390/jcm12237243. J Clin Med. 2023. PMID: 38068295 Free PMC article.
Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study.
Barrero F, Mallada-Frechin J, Martínez-Ginés ML, Marzo ME, Meca-Lallana V, Izquierdo G, Ara JR, Oreja-Guevara C, Meca-Lallana J, Forero L, Sánchez-Vera I, Moreno MJ; in representation of the MS NEXT study investigators. Barrero F, et al. Among authors: forero l. PLoS One. 2020 Apr 2;15(4):e0230846. doi: 10.1371/journal.pone.0230846. eCollection 2020. PLoS One. 2020. PMID: 32240213 Free PMC article.
Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23).
Martínez-Ginés ML, García-Domínguez JM, Forero L, Canal N, Rebollo P, Prefasi D, Honan CA, Maurino J. Martínez-Ginés ML, et al. Among authors: forero l. Mult Scler Relat Disord. 2018 May;22:115-119. doi: 10.1016/j.msard.2018.04.003. Epub 2018 Apr 3. Mult Scler Relat Disord. 2018. PMID: 29656271
70 results